Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS).
Clinical trial NCT01835587 · COMPLETED
Trial details
- NCT number
- NCT01835587
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-25
- Primary completion
- 2016-11-13
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.